Avia Pharma signs license agreement for Femarelle

Avia Pharma signs license agreement for Femarelle

With a strong foot print in women’s health Avia Pharma are trusted to launch Femarelle in Finland.
“We are proud and excited to launch Femarelle, with such extensive studies proven its effect for women during the menopausal transition. I am sure that we can make a difference to these women and are looking forward to our co-operation with Se-cure” says Marie Wikman, Business Director OTC at Avia Pharma.

Femarelle is the most recommended non-hormonal option, endorsed by leading gynecologists around the world. Backed by science and sales of millions of units to date, the Femarelle line provides women around the globe a safe and effective option to alleviate their menopausal symptoms.